Moreover, patients without echocardiographic signs of CHD, but with NT-proBNP levels >27 pmol/L, could possibly benefit from more active screening than is currently advised by European guidelines [15], for instance, by six monthly echocardiography. Here, NPPB is linked to coronary artery disorder.